Cost effectiveness
Economic evaluations of vaccines in Canada: a scoping review
This study aims to summarize and describe the evolution of published economic evaluations of vaccines in Canada, thereby outlining the current state of this expanding and meaningful research.
Cost benefit of vaccines (from Canadian Immunization Guide)
Vaccine-preventable diseases result in significant costs to individuals, the health care system, and society, including costs associated with absenteeism from work or school, visits to health care providers, hospitalizations, and premature deaths. In addition to being one of the most beneficial, immunization is also one of the most cost-effective public health interventions.
Coûts-avantages des vaccins (du Guide canadien d'immunisation)
Les maladies évitables par la vaccination engendrent des coûts considérables pour les individus, le système de soins de santé et la société, notamment des coûts associés à l’absentéisme au travail ou à l’école, aux consultations auprès de fournisseurs de soins de santé, aux hospitalisations et aux décès prématurés. L’immunisation est l’une des interventions en santé publique les plus bénéfiques et les plus économiques.
Economic evaluation of vaccines in Canada: A systematic review
A systematic review of economic evaluations of vaccines in Canada to determine and summarize comprehensiveness across jurisdictions, studied vaccines, funding sources, study designs, research quality, and changes over time.
Systematic Review of the Cost-Effectiveness of Influenza Immunization Programs: A Canadian Perspective
For adults with co-morbidities and healthcare workers, vaccination was cost-effective. In Canada, six provinces (AB, SK, MB, ON, NS, NL) and all territories offer universal programs as of 2014. Three provinces (BC, QC, NB) offer programs targeting high risk groups only.
Cost effectiveness of infant vaccination for rotavirus in Canada
Rotavirus is the main cause of gastroenteritis in Canadian children younger than five years of age, resulting in significant morbidity and cost. The present study provides evidence on the cost-effectiveness of two alternative rotavirus vaccinations available in Canada.
Time for change? An economic evaluation of integrated cervical screening and HPV immunization programs in Canada
Many jurisdictions have implemented universal human papillomavirus (HPV) immunization programs in preadolescent females. However, the cost-effectiveness of modified cervical screening guidelines and/or catch-up immunization in older females in Canada has not been evaluated. Researchers conducted a cost-utility analysis of screening and immunization with the bivalent vaccine for the Canadian setting from the Ministry of Health perspective. They used a dynamic model to capture herd immunity and included cross-protection against strains not included in the vaccine. They found that adding catch-up immunization to the current program would be cost-effective, and that combining catch-up immunization with delaying the age at which screening is first initiated could result in cost savings and net health gains.
Vaccine research, development and awareness : front line medicine
A special information supplement from the March 5, 2010 issue of the Globe and Mail that celebrates and promotes Canada’s contributions in the development and distribution of disease-fighting vaccines.
Cost Effectiveness of Herpes Zoster Vaccine in Canada
Compares the incremental cost and health benefits of herpes zoster (HZ) vaccine over status quo (no HZ vaccine) from the perspective of the Canadian healthcare payer.
Immunisation, infections et le rôle de l'école dans la vaccination
L'immunisation des enfants et des jeunes en milieu scolaire est considérée à nouveau comme une mesure économique et avantageuse tant pour la santé que pour le rendement scolaire. Le présent article examine certaines données probantes, commente des expériences au Canada et dans d'autres pays et mentionne quelques bons programmes.